A Registry Study on Serumal Biomarkers About Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.

• Conditions: Cardiac Surgery

• Registration Number: NCT04107571
• Lead Sponsor: Beijing Institute of Heart, Lung and Blood Vessel Diseases

Brief Summary

This is a national registry study to determine the serumal biomarkers for prognosis of adverse events in patients undergoing coronary artery bypass grafting.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-01
• Status Verified: 2019-09
• Study First Submitted: 2019-09-26
• Study First Submitted QC: 2019-09-26
• Last Update Submitted: 2019-09-26
• Study First Posted: 2019-09-27
• Last Update Posted: 2019-09-27
• Primary Completion: 2024-01
• Study Completion: 2024-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

1. Subject undergoing coronary artery bypass grafting;
2. Age is more than 18 and less than 80 years old;
3. Male and non pregnancy female;
4. Subject who understands study requirements and agrees to sign an informed consent from prior to study procedures.

Exclusion Criteria

1. Pregnancy female;
2. Participate in other clinical trial in the last 1 month.
3. Subject who doesn't agree to sign an informed consent from prior to study procedures.
4. Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All-cause death and cardiac death	These data is collected during follow-up visit at in-hospital/1 year after discharge

Secondary Outcome Measures

Name	Time	Method
Major adverse cardiac events (MACE)	These data is collected during follow-up visit at in-hospital/1 year after discharge	A composite of death, myocardial infarction, stroke, heart failure, ventricular arrhythmia

Trial Locations

Locations (1)

Beijing Anzhen Hospital; 🇨🇳 Beijing, China